BPC-157 resists that degradation, a structural quirk that makes it unusually versatile among peptide therapies
Cycles typically run 3 to 6 months with off-cycles of similar length
10.1097/IJG.0000000000001071 36 TovarA.GomezA.SerranoA.BlancoM
Treating comorbidities ME/CFS displays an overlap with several autoimmune or immune-mediated diseases that also have chronic fatigue as a main symptom, such as Hashimotos thyroiditis (530), fibromyalgia (FM) (532, 554557), Mast Cell Activation Disorder (532), sleep apnoea (532), IBS (532), secondary depression or anxiety (532), Ehlers-Danlos syndrome (532), and PoTS (532, 558563)
Skin thickness and firmness: Clinical studies using topical copper peptide formulations documented measurable improvements in skin density, elasticity, and laxity reduction in human volunteers